Treatment Of Patients With Classic Fabry Disease

Patent No. EP3749308 (titled "Treatment Of Patients With Classic Fabry Disease") was filed by Amicus Therapeutics on Feb 6, 2019. The application was issued on Oct 25, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJul 25, 2024D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3749308

AMICUS THERAPEUTICS
Application Number
EP19706182A
Filing Date
Feb 6, 2019
Status
Granted And Under Opposition
Sep 22, 2023
Publication Date
Oct 25, 2023